Mycophenolic Acid: all 424 studies that test it
Page 1 of 5. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA NephropathyNot yet recruitingNCT07785128Phase 2
- Mycophenolate After Stem Cell Transplant for Systemic SclerosisNot yet recruitingNCT07734012Phase 2
- Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor TherapyRecruitingNCT07663422Phase 2
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingNCT07634536Phase 2
- Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain CancerNot yet recruitingNCT07605364Phase 2/3
- HORUS-Cytomegalovirus Open Proof-of-concept Exploratory TrialNot yet recruitingNCT07570433Phase 4
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingNCT07524530Phase 2
- The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil TreatmentRecruitingNCT07340463Phase 2
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingNCT06996119Phase 1
- A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host DiseaseRecruitingNCT06973668Phase 2
- Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell TransplantationRecruitingNCT06807606Phase 2
- Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic HepatitisNot yet recruitingNCT06789315Not applicable
- Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?RecruitingNCT06676384Phase 4
- Short-term Glucocorticoid Combined with MMF for IgG4-RDRecruitingNCT06663618Not applicable
- Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.RecruitingNCT06568549Phase 4
- A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of RecurrenceRecruitingNCT06468709Phase 4
- Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein PurpuraRecruitingNCT05951517Not applicable
- Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus ErythematosusRecruitingNCT05916781Phase 4
- Allo HSCT Using RIC and PTCy for Hematological DiseasesRecruitingNCT05805605Phase 2
- Treatment Strategies for IgG4-RD Patients With Internal Organ InvolvementRecruitingNCT05789017Not applicable
- Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung DiseaseRecruitingNCT05785065Phase 2
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingNCT05736419Phase 2
- The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyRecruitingNCT05538208Phase 2
- MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LNRecruitingNCT05495893Phase 4
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M NeuroblastomaNot yet recruitingNCT05303727Phase 2
- Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus NephritisRecruitingNCT05207358Phase 4
- New Clinical End-points in Patients With Primary Sjögren's SyndromeRecruitingNCT05113004Phase 2
- Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell TransplantationRecruitingNCT04868786Phase 1
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersRecruitingNCT04644016Phase 2
- BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)RecruitingNCT04187105Phase 2
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant RecipientsEnrolling by invitationNCT03292861Phase 2
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute LeukemiaRecruitingNCT03128034Phase 1/2
- Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell DiseaseRecruitingNCT03121001Phase 2
- Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruitingNCT02416388Phase 2/3
- Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossRecruitingNCT01999361Not applicable
- Allogeneic Hematopoietic Stem Cell Transplant for GATA2 MutationsRecruitingNCT01861106Phase 2
- Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic LupusTerminatedNCT05306873Phase 2Results posted
- Off-the-shelf NK Cells + SCT for Myeloid MalignanciesCompletedNCT05115630Phase 2Results posted
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye DiseaseCompletedNCT04734197Phase 2Results posted
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young AdultsTerminatedNCT04530487Phase 2Results posted
- Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple MyelomaTerminatedNCT04205240Phase 2Results posted
- Treg Modulation With CD28 and IL-6 Receptor AntagonistsCompletedNCT04066114Phase 1/2Results posted
- TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)CompletedNCT03959241Phase 3Results posted
- 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological MalignanciesCompletedNCT03712878Phase 2Results posted
- Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or DysregulationActive, not recruitingNCT03663933Phase 2Results posted
- Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant RecipientsCompletedNCT03663335Phase 2Results posted
- Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' ExpressionCompletedNCT03480360Phase 3Results posted
- MMF for HIV Reservoir ReductionCompletedNCT03262441Phase 2Results posted
- Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationTerminatedNCT03246906Phase 2Results posted
- Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaCompletedNCT03096782Phase 2Results posted
- Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCTCompletedNCT03018223Phase 1Results posted
- Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal TransplantationTerminatedNCT02974686Phase 4Results posted
- Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant RecipientsCompletedNCT02954198Not applicableResults posted
- Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)CompletedNCT02918292Phase 2Results posted
- Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best DonorCompletedNCT02880293Not applicableResults posted
- NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic AnemiaCompletedNCT02833805Phase 2Results posted
- Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell TransplantationActive, not recruitingNCT02782546Phase 2Results posted
- Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid NeoplasmsCompletedNCT02756572Phase 2Results posted
- TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed LymphomaCompletedNCT02652468Not applicableResults posted
- Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and CorticosteroidsTerminatedNCT02630563Phase 2Results posted
- Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02566304Phase 2Results posted
- JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisCompletedNCT02251821Phase 2Results posted
- Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic AnemiaCompletedNCT02224872Phase 2Results posted
- Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHDCompletedNCT02220985Phase 2Results posted
- Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)CompletedNCT02208037Phase 2Results posted
- Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative RegimenTerminatedNCT02199041Phase 2Results posted
- A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.CompletedNCT02091414Phase 3Results posted
- A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus NephritisTerminatedNCT02081183Phase 3Results posted
- Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)TerminatedNCT02080195Phase 1/2Results posted
- OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.CompletedNCT02005562Phase 3Results posted
- Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical DonorCompletedNCT01982682Phase 2Results posted
- Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD PreventionCompletedNCT01951885Phase 3Results posted
- Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)TerminatedNCT01946880Phase 2Results posted
- Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT01904136Phase 1/2Results posted
- A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic HepatitisCompletedNCT01903798Phase 2Results posted
- Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01884571Phase 2Results posted
- Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTerminatedNCT01871441Phase 2Results posted
- Non-Myeloablative Conditioning and Bone Marrow TransplantationActive, not recruitingNCT01850108Not applicableResults posted
- Methotrexate and Mycophenolate Mofetil for UVEITISCompletedNCT01829295Phase 3Results posted
- Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord TransplantationCompletedNCT01810588Phase 2Results posted
- Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic MalignancyCompletedNCT01807611Phase 2Results posted
- Influence of Pantoprazole on the Bioavailability of MMF and EC-MPSCompletedNCT01801280Phase 4Results posted
- Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic MalignanciesCompletedNCT01760655Phase 2Results posted
- Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive RegimensCompletedNCT01653847Not applicableResults posted
- Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal DisordersCompletedNCT01626092Not applicableResults posted
- T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic TransplantTerminatedNCT01621477Phase 2Results posted
- Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + CorticosteroidsCompletedNCT01601821Phase 4Results posted
- Crohn's Allogeneic Transplant StudyTerminatedNCT01570348Phase 2Results posted
- Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological MalignanciesCompletedNCT01527045Phase 2Results posted
- Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD PreventionCompletedNCT01487577Phase 2Results posted
- Cellcept for Treatment of Juvenile Neuronal Ceroid LipofuscinosisCompletedNCT01399047Phase 2Results posted
- A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesCompletedNCT01384513Phase 2Results posted
- Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative DonorCompletedNCT01350245Phase 2Results posted
- Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT01341301Phase 2Results posted
- Evaluate Effects and Safety of Pre-load Myfortic® in Transplant PatientsCompletedNCT01336296Phase 4Results posted
- Research Study of ATG and Rituximab in Renal TransplantationTerminatedNCT01318915Early Phase 1Results posted
- A Study of the Correlation Between Pharmacokinetic and Pharmacodynamic Parameters of CellCept (Mycophenolate Mofetil).CompletedNCT01292226Phase 2Results posted
- Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous NephropathyCompletedNCT01282073Phase 3Results posted